Related references
Note: Only part of the references are listed.Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome
Dezhi Cao et al.
EPILEPSIA (2012)
Concentrations of Stiripentol in Children and Adults With Epilepsy: The Influence of Dose, Age, and Comedication
Theodor W. May et al.
THERAPEUTIC DRUG MONITORING (2012)
Current therapeutic procedures in Dravet syndrome
Catherine Chiron
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2011)
Dravet syndrome history
Charlotte Dravet
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2011)
Cognitive and behavioral characteristics of children with Dravet syndrome: An overview
Francesco Guzzetta
EPILEPSIA (2011)
Mortality in Dravet syndrome: Search for risk factors in Japanese patients
Masako Sakauchi et al.
EPILEPSIA (2011)
The pharmacologic treatment of Dravet syndrome
Catherine Chiron et al.
EPILEPSIA (2011)
The effects of stiripentol on GABAA receptors
Janet L. Fisher
EPILEPSIA (2011)
Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: A prospective pilot study
Rima Nabbout et al.
EPILEPSIA (2011)
Interactions between modulators of the GABAA receptor: Stiripentol and benzodiazepines
Janet L. Fisher
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Dravet Syndrome: Inroads into Understanding Epileptic Encephalopathies
Richard P. Morse
JOURNAL OF PEDIATRICS (2011)
Stiripentol open study in Japanese patients with Dravet syndrome
Yushi Inoue et al.
EPILEPSIA (2009)
The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator
Janet L. Fisher
NEUROPHARMACOLOGY (2009)
Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome) - A nationwide questionnaire survey in Japan
Takuya Tanabe et al.
BRAIN & DEVELOPMENT (2008)
Severe myoclonic epilepsy in infancy:: A systematic review and a meta-analysis of individual patient data
Behrouz Kassaie et al.
EPILEPSIA (2008)
An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy
P. Striano et al.
NEUROLOGY (2007)
Topiramate in the treatment of highly refractory patients with Dravet syndrome
J. Kroll-Seger et al.
NEUROPEDIATRICS (2006)
Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABAA-receptor channels
PP Quilichini et al.
EPILEPSIA (2006)
In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism
C Giraud et al.
DRUG METABOLISM AND DISPOSITION (2006)
Severe myoclonic epilepsy of infants (Dravet syndrome): Natural history and neuropsychological findings
Markus Wolff et al.
EPILEPSIA (2006)
Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human
N Cazali et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Topiramate in the treatment of severe myoclonic epilepsy in infancy
M Nieto-Barrera et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2000)
Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial
C Chiron et al.
LANCET (2000)
Share Paper
